The 2-Minute Rule for Healthcare News
FTC sues big pharmacy advantage supervisors more than insulin price ranges The company introduced motion versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record cost of lifestyle-conserving insulin medicine.Never pass up tomorrow's healthcare industry